Fondaparinux Sodium Injection
Product Images NDC 0781-3465

Product Visual Gallery

This gallery contains 34 technical images submitted to the FDA as part of the official labeling for Fondaparinux Sodium (NDC 0781-3465). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sandoz Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (Figure 1 1)

An instructional illustration showing a pair of gloved hands preparing a syringe filled with a medication injection. The image emphasizes proper handling techniques for subcutaneous injection, with an arrow indicating the direction of manipulation on the syringe.*

FDA Label Image

Image Description (Figure 2 1)

An instructional illustration showing a medical professional administering a subcutaneous injection into a patient's upper arm or shoulder area using a syringe and needle. The image depicts the injection procedure relevant to subcutaneous injectable drugs like Fondaparinux Sodium.*

FDA Label Image

Image Description (Figure 3 1)

A black-and-white photograph showing a person administering a subcutaneous injection in the abdominal area. The image focuses on the hands holding a syringe and injecting the solution beneath the skin, illustrating the injection method relevant to Fondaparinux Sodium, an injectable anticoagulant drug.*

FDA Label Image

Image Description (Figure 4 1)

A black-and-white instructional photograph showing a healthcare professional administering a subcutaneous injection into a patient's upper arm. The image focuses on the injection technique using a syringe, with gloved hands holding the syringe and the patient's arm exposed for the injection site.*

FDA Label Image

Image Description (Figure 5 1)

Fondaparinux Sodium injection in a prefilled syringe, held in hand. The syringe contains a clear solution and is labeled with dosage and product information. The product is for subcutaneous use, provided by Sandoz Inc. Visible dosage strength or volume is not fully legible in the image.*

FDA Label Image

Image Description (Figure 6 1)

An instructional illustration showing a hand holding a prefilled syringe of Fondaparinux Sodium injection, demonstrating how to remove the needle cap by pulling it straight off in the direction indicated by an arrow. The syringe is transparent and labeled, suitable for subcutaneous administration.*

FDA Label Image

Image Description (Structural Formula)

Chemical structure diagram of Fondaparinux Sodium, illustrating its molecular arrangement with multiple sodium sulfate and carboxylate groups attached to a sugar-based backbone.*

FDA Label Image

Image Description (Syringe Looks)

Illustration of a syringe calibrated in milliliters from 0.0 to 0.9 mL, used for subcutaneous injection of Fondaparinux Sodium. The syringe features a needle, barrel with measurement markings, and a plunger. No additional labeling or text is visible.*

FDA Label Image

Image Description (Syringe 2)

Fondaparinux Sodium injection prefilled syringe, designed for subcutaneous use. The syringe has a graduated barrel marked with volume measurements and a plunger for dosage administration. No specific strength or volume is visible on the syringe in the image. Manufactured by Sandoz Inc.*

FDA Label Image

Image Description (Figure A 1)

An instructional diagram illustrating a human torso highlighting the lower stomach area (abdomen) as the site for subcutaneous injection. The shaded region indicates the recommended injection area for Fondaparinux Sodium injection.*

FDA Label Image

Image Description (Figure B 1)

An instructional illustration showing a person preparing a subcutaneous injection with a syringe and vial or injection device. The image depicts proper technique for drawing medication into the syringe, relevant to Fondaparinux Sodium injection use.*

FDA Label Image

Image Description (Figure C 1)

An instructional line drawing showing a hand pinching or lifting a fold of skin, typically illustrating a step for subcutaneous injection administration.*

FDA Label Image

Image Description (Figure D 1)

An instructional diagram showing a hand holding a syringe and injecting it into the skin at a 90-degree angle. The illustration demonstrates the correct angle and method for subcutaneous injection, indicated by an arrow pointing downward into the skin.*

FDA Label Image

Image Description (Figure E 1)

An instructional illustration showing the proper technique for using a syringe. It depicts one hand holding the syringe vertically with the plunger being pushed down by the other hand, indicated by a downward arrow.*

FDA Label Image

Image Description (Figure F 1)

An instructional illustration showing a person administering a subcutaneous injection using a syringe. One hand pinches the skin to form a fold, while the other inserts the syringe needle at an upward angle, indicating the technique for subcutaneous injection.*

FDA Label Image

Image Description (Syring Looks1)

Fondaparinux Sodium injection prefilled syringe, showing the clear plastic syringe barrel and plunger. The syringe is labeled for subcutaneous administration and is supplied by Sandoz Inc. No strength or volume is visible in the image.*

FDA Label Image

Image Description (Syringe 1)

Fondaparinux Sodium injection prefilled syringe showing a clear barrel with volume markings and a black plunger stopper, a white plunger handle, and a needle cover. The syringe is labeled with the proprietary name Fondaparinux Sodium. The medication is intended for subcutaneous use and manufactured by Sandoz Inc.*

FDA Label Image

Image Description (Before Use)

Fondaparinux Sodium injection in a prefilled syringe, designed for subcutaneous administration. The syringe contains clear liquid and includes a plunger, barrel with measurement markings, and a needle. The image shows a detailed side view of the syringe components with black numbered labels on parts of the syringe. The product is labeled under Sandoz Inc.*

FDA Label Image

Image Description (After Use)

Fondaparinux Sodium injection in a prefilled syringe designed for subcutaneous use. The image shows a clear syringe with visible internal piston and needle cover, labeled with measurement increments. The syringe is likely part of the Sandoz Inc. product line available in multiple strengths, including 2.5 mg/.5 mL seen here.*

FDA Label Image

Image Description (Figure A)

A black-and-white photo showing a person with their shirt lifted to expose the abdomen. One hand is positioned just above the belt line, and the image suggests preparation for subcutaneous injection in the abdominal area. This illustration relates to administering Fondaparinux Sodium injection subcutaneously.*

FDA Label Image

Image Description (Figure B)

An instructional illustration showing two hands holding a prefilled syringe of Fondaparinux Sodium injection. An arrow indicates a step in the preparation or administration process, likely related to removing the needle cap or preparing for subcutaneous injection.*

FDA Label Image

Image Description (Figure C)

A black and white photograph showing a person's abdominal area with two hands demonstrating pinching the skin to lift it. Two arrows point towards the pinched skin area, indicating the site for a subcutaneous injection. This image illustrates proper technique for administering a subcutaneous injection, relevant for Fondaparinux Sodium injection use.*

FDA Label Image

Image Description (Figure D)

Black and white photograph showing a healthcare professional administering a subcutaneous injection into the forearm of a patient. The image depicts a close-up of the injection technique with the syringe in place, illustrating the proper method of delivering a subcutaneous injection.*

FDA Label Image

Image Description (Figure E)

Illustration showing a person self-administering a subcutaneous injection using a prefilled syringe, relevant to Fondaparinux Sodium injection for subcutaneous use.*

FDA Label Image

Image Description (Figure F)

An illustration showing a person administering a subcutaneous injection with a syringe into the abdomen. The image depicts the proper technique for injecting Fondaparinux Sodium, highlighting the subcutaneous route of administration.*

FDA Label Image

Image Description (Figure G)

FDA Label Image

Image Description (2 5mg 2pack)

Fondaparinux Sodium Injection, USP 2.5 mg per 0.5 mL single-dose prefilled syringes packaging label. The label states it is for subcutaneous injection, Rx only, and contains two prefilled syringes with an automatic needle protection system. Manufactured by Jiangsu Hengrui Pharmaceuticals Co., Ltd. for Sandoz Inc. The label includes storage instructions and a barcode.*

FDA Label Image

Image Description (5mg 2pack)

Box packaging label for Fondaparinux Sodium Injection USP, 5 mg per 0.4 mL, a subcutaneous injection by Sandoz Inc. The label states it contains 2 single-dose prefilled syringes with an automatic needle protection system. Manufactured in China by Jiangsu Hengrui Pharmaceuticals Co., Ltd., the label includes storage instructions and directions to dispense a patient information leaflet.*

FDA Label Image

Image Description (2 5mg 10pack)

Carton packaging for Fondaparinux Sodium Injection, USP 2.5 mg per 0.5 mL, a subcutaneous injection by Sandoz Inc. The label indicates 10 single-dose prefilled syringes with an automatic needle protection system. The box includes storage instructions, manufacturer details (Jiangsu Hengrui Pharmaceuticals Co., Ltd., China), and usage information stating Rx only and pharmacist dispensing instructions.*

FDA Label Image

Image Description (5mg 10pack)

Packaging label for Fondaparinux Sodium Injection, USP 5 mg per 0.4 mL, produced by Sandoz Inc. The label states it is for subcutaneous injection and contains 10 single-dose prefilled syringes with automatic needle protection. Manufactured in China by Jiangsu Hengrui Pharmaceuticals Co., Ltd., the label includes storage instructions and the NDC 0781-3454-95.*

FDA Label Image

Image Description (7 5mg 2pack)

Packaging label for Fondaparinux Sodium Injection, USP 7.5 mg per 0.6 mL, a subcutaneous injection presented in two single-dose prefilled syringes. Manufactured for Sandoz Inc. and produced by Jiangsu Hengrui Pharmaceuticals in China. The label includes storage instructions, dosage recommendation, and notes on automatic needle protection and patient information leaflet dispensing.*

FDA Label Image

Image Description (7 5mg 10pack)

Packaging label for Fondaparinux Sodium Injection, USP 7.5 mg per 0.6 mL, a subcutaneous injection supplied as 10 single-dose prefilled syringes. The label includes dosing instructions, storage conditions, manufacturer information (Jiangsu Hengrui Pharmaceuticals for Sandoz Inc.), and a barcode. The product is Rx only and includes an automatic needle protection system.*

FDA Label Image

Image Description (10mg 2pack)

Fondaparinux Sodium Injection, USP 10 mg per 0.8 mL single-dose prefilled syringes. The label states the product is for subcutaneous injection, includes 2 syringes per package, and is labeled for prescription use only. Manufactured by Jiangsu Hengrui Pharmaceuticals for Sandoz Inc., this package includes an automatic needle protection system and instructions to dispense a patient information leaflet.*

FDA Label Image

Image Description (10mg 10pack)

Fondaparinux Sodium Injection, USP 10 mg per 0.8 mL subcutaneous injection, in a carton labeled for 10 single-dose prefilled syringes. The label includes manufacturer information, storage instructions, and barcode. The product is from Sandoz Inc., with manufacturing by Jiangsu Hengrui Pharmaceuticals Co., Ltd., China.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.